Physician
Hematology
Dr. Paul V. Woolley III, MD
|
|
Give Review
Paul Woolley is an expert in the field of Hematology. He researched medicine at University of Michigan Medical School. Paul V. Woolley III is also a published doctor. He has 97 publication published. The most recent publication is: Seminars in oncology. Introduction. Paul Woolley accepts Medicare.
Publications
- Deep vein thrombosis, ecythyma gangrenosum and heparin-induced thrombocytopenia occurring in a man with a heterozygous Factor V Leiden mutation.
- A case of chronic myelogenous Leukemia in pregnancy characterized by a complex translocation t(9;22;11)(q34;q11.2;q13).
- Cytogenetics, immunostaining for fibroblast growth factors, p53 sequencing, and clinical features of two cases of cystosarcoma phyllodes.
- A phase II trial of CI-958 in patients with hormone-refractory prostate Cancer.
- Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group.
- A phase II trial of ilmofosine in non-small cell bronchogenic carcinoma.
- Continuous infusion 5-fluorouracil with bolus adriamycin and mitomycin and low-dose cisplatin (FAMP) in the treatment of metastatic gastric carcinoma: an evaluation of...
- Antitumor activity of liposome-encapsulated doxorubicin in advanced breast Cancer: phase II study.
- A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin.
- Phase II trial of methotrexate-FAM (m-FAM) in adenocarcinoma of unknown primary.
- Cancer-associated hemolytic-uremic syndrome: Analysis of 85 cases from a national registry.
- Therapy of advanced gastric carcinoma. The Georgetown-Lombardi Cancer Center experience.
- Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy.
- Electrostatic potential of macromolecules measured by pKa shift of a fluorophore. 2. Transfer RNA.
- Therapeutic and pharmacological studies of tetrachloro(d,l-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum Analogue.
- Cancers of the large bowel, pancreas and hepatobiliary tract.
- Ascorbate potentiates DNA damage by 1-methyl-1-nitrosourea in vivo and generates DNA strand breaks in vitro.
- Treatment of first-attack genital herpes--acyclovir versus inosine pranobex.
- FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the P...
- Cancers of the large bowel and hepatobiliary system.
- Phase I combined modality clinical trial of alpha-2-interferon and radiotherapy.
- Phase II trial of aclarubicin in epidermoid carcinoma of the head and neck.
- Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, measurable adenocarcinoma of the Lung and stomach.
- Treatment of Cancer-associated hemolytic uremic syndrome with staphylococcal protein A immunoperfusion.
- Phase I study of echinomycin administered on an intermittent bolus schedule.
- Phase I study and clinical pharmacology of 6-diazo-5-oxo-L-norleucine (DON).
- A controlled trial of the effect of 4-hydroxypyrazolopyrimidine (allopurinol) on the toxicity of a single bolus dose of 5-fluorouracil.
- Phase II trial of PCNU in advanced Renal cell carcinoma and malignant melanoma.
- Phase-II study of cis-diammine-dichloro platinum (cis-platinum), bleomycin and methotrexate for advanced squamous cell carcinoma of head and neck.
- Thermal melting of chromatin from the pancreas and Liver of guinea pigs treated with 1-methyl-1-nitrosourea.
- Pharmacological disposition of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in mice.
- A Phase I trial of spirogermanium administered on a continuous infusion schedule.
- Methotrexate-induced Immune haemolytic anaemia.
- Dangers of potassium in calcium supplements.
- Combination chemotherapy for locally advanced pancreatic Cancer: equivalence to external beam irradiation and implication for future management.
- Hepatic and Pancreatic damage produced by cytotoxic drugs.
- The effect of sequential addition of the nitrosourea, chlorozotocin, to the FAM combination in advanced gastric Cancer.
- Clinical trial of the effect of S-2-(3-aminopropylamino)-ethylphosphorothioic acid (WR-2721) (NSC 296961) on the toxicity of cyclophosphamide.
- Phase II trial of mitoguazone in patients with advanced squamous cell carcinoma of the head and neck.
- Distance measurement by energy transfer: the 3'' end of 16-S RNA and proteins S4 and S17 of the ribosome of Escherichia coli.
- Phase II study of 5-FU, doxorubicin, and mitomycin (FAM) and chlorozotocin in advanced measureable pancreatic Cancer.
- Current management of advanced and locally unresectable gastric carcinoma.
- Phase II trial of mitoxantrone in advanced coloRectal cancer.
- Editorial on management of drug toxicity.
- Phase II studies of methyl glyoxal bis-guanylhydrazone (NSC 32946) in carcinoma of the colon and Lung.
- A phase I clinical trial of aclacinomycin A administered on a five-consecutive-day schedule.
- Distribution and binding of the carcinogens 1-methyl-1-nitrosourea and 1-methyl-3-nitro-1-nitrosoguanidine in the guinea pig after oral administration.
- Fast neutron irradiation for locally advanced pancreatic Cancer.
- Phase II study of chlorozotocin in Leukemia and other hematologic malignancies.
- Phase II study of PCNU in coloRectal carcinoma.
- Phase I trial and clinical pharmacology of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea.
- Binding of N-nitroso carcinogens in Pancreatic tissue.
- CAMP (cyclophosphamide, doxorubicin, methotrexate, and procarbazine) for epidermoid and large cell anaplastic carcinoma of the Lung.
- The FAM regimen for gastric Cancer: a progress report.
- Phase II trial of methyl-G (methylglyoxal bis-guanylhydrazone) in patients with metastatic Renal cell carcinoma.
- 5-fluorouracil, Adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas.
- A phase II study of chlorozotocin in metastatic malignant melanoma.
- Phase I clinical trial of spirogermanium.
- 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric Cancer.
- Uptake and binding of 1-methyl-1-nitrosourea (MNU) and 1-methyl-3-nitro-1-nitrosoguanidine (MNNG) by the isolated guinea pig pancreas.
- Liposomal protection of adriamycin-induced cardiotoxicity in mice.
- Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion.
- Clinical strategies in the chemotherapy of gastrointestinal Cancer.
- A phase II trial of ftorafur: adriamycin and mitomycin-C (FAM II) in advanced gastric adenocarcinoma.
- Delayed radiation necrosis of brainstem related to fast neutron beam irradiation: case report and literature review.
- 5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric Cancer.
- Possibilities for a role of L-glutamine and L-asparagine antagonists in the treatment of gastrointestinal Cancer.
- 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy for adenocarcinoma of the Lung.
- Nitrosourea interaction with chromatin and effect on poly(adenosine diphosphate ribose) polymerase activity.
- Modification of L1210 cell nuclear proteins by 1-methyl-1-nitrosourea and 1-methyl-3-nitro-1-nitrosoguanidine.
- Phase-II trial of tamoxifen in advanced breat Cancer.
- Probable clonal origin of Acute myeloblastic leukemia following radiation and chemotherapy of colon cancer.
- Double aneuploidy: partial trisomy 21 and XO/XXX in a family with 12/21 translocation.
- Pharmacologic disposition of chlorozotocin in mice.
- Phase I studies on chlorozotocin.
- A developmental assessment chart for non-institutionalized Down syndrome children.
- Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced coloRectal cancer.
- Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic Cancer.
- Pharmacology of nitrosourea antitumor agents.
- Hepatic estrogen and progesterone receptors in an estrogen-associated hepatic neoplasm.
- Ongoing trials in the surgical adjuvant management of coloRectal cancer.
- Mitomycin C: experience in the United States, with emphasis on gastric Cancer.
- Electrostatic interactions at charged lipid membranes. Can the lipid phase transformation affect enzyme activity through the mediation of protons?
- Clinical manifestations of Cancer of the colon and rectum.
- Seminars in oncology. Introduction.
- Chemotherapy of coloRectal carcinoma.
- 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced coloRectal cancer: phase II study utilizing weekly 5-FU.
- Therapeutic use of tamoxifen in advanced breast Cancer: correlation with biochemical parameters.
- Bilirubin and biLiverdin binding to rat Y protein (ligandin).
- Extranodal presentation of non-Hodgkin''s Lymphomas in the testis.
- Familial partial trisomy 6q Syndromes resulting from inherited ins (5;6) (q33;q15q27).
- Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent.
- An extra small metacentric chromosome identified as a deleted chromosome no. 17.
- Binding of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea to L1210 cell nuclear proteins.
- Models for metal ion function in carbonic anhydrase.
- Mesomelic dwarfism as the homozygous expression of dyschondrosteosis.
Schools
University of Mi Med Sch
Roosevelt Hospital
NciNih
Procedures Preformed
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Breast Cancer
- View All
Doctors Specialties
- Hematology
- Oncology
Accepted Insurances
Education
-
St Luke's-Roosevelt Hospital Center -
University of Michigan Medical School
Helpful Reviews
Similar Doctors
|
|
Dr. Richard A. Pinkerton, DO |
|
|
Dr. William R. Wynert, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harold G. Ashcraft, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hasan Bit-Shawish, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James C. Moore, MD |
|
|
Dr. Gopala A. Ramineni, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark M. Keating, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael D. Voloshin, MD |
|
|
Dr. Mariya H. Apostolova, MD |